"Moderna’s Covid-19 vaccine saved millions of lives and made the biotech group one of America’s fastest-growing companies. But a plunge in sales of the jab due to the easing of the pandemic could push Moderna back into the red this year, as it races to prove it is not a “one-trick pony” with a single product"

https://www.ft.com/content/5fc71e17-541c-4fe8-a2cb-ae7d17917366